No image

AccuPlex™

0505-0001 · Lgc Clinical Diagnostics, Inc.

AccuPlex rEbola GP/NP Reference Material 5 x 0.25 mL

Details

Device typeEbola virus nucleic acid IVD, control: A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of nucleic acid from one or multiple strains of Ebola virus in a clinical specimen.

FDA categoryWhole Human Serum, Antigen, Antiserum, Control

Device ID00816784020017

Catalog number0505-0001

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
ACCURUN®Lgc Clinical Diagnostics, Inc.Rubella virus immunoglobulin G (IgG) antibody IVD, control	2015-0084	Lgc Clinical Diagnostics, Inc.	Rubella virus immunoglobulin G (IgG) antibody IVD, control
D3Diagnostic Hybrids, Inc.Herpes simplex virus 1 & 2 (HSV1 & 2) antigen IVD, control	01-095005	Diagnostic Hybrids, Inc.	Herpes simplex virus 1 & 2 (HSV1 & 2) antigen IVD, control
CMV IgG ControlBion Enterprises, Ltd.Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control	CMG-2020	Bion Enterprises, Ltd.	Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control
PreciControl Anti-CMVRoche Diagnostics GmbHCytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control	04784600162	Roche Diagnostics GmbH	Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, control